Regarding the association between the number of doses of remdesivir and elevated liver enzymes in patients with COVID-19 receiving remdesivir, there was no correlation between the number of doses of remdesivir received and increases in the enzymes ALT, ALP, and total bilirubin, but patients who received more doses of remdesivir had elevated AST. The gene discussed is GPT; the disease is COVID-19.